Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Epidemiology and Infection|February 13, 2015
High prevalence of hepatitis C (HCV) in the emergency department (ED) of a London hospital: should we be screening for HCV in ED attendees?C Orkin, E Leach, S Flanagan, et al.
Epidemiology and Infection|April 18, 2018
Implementing routine blood-borne virus testing for HCV, HBV and HIV at a London Emergency Department - uncovering the iceberg?S Parry, N Bundle, S Ullah, et al.
HIV Medicine|October 24, 2012
Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trialC Orkin, E DeJesus, H Khanlou, et al.
HIV Medicine|December 6, 2011
Twenty-four-week efficacy and safety of switching virologically suppressed HIV-1-infected patients from nevirapine immediate release 200 mg twice daily to nevirapine extended release 400 mg once daily (TRANxITION)K Arasteh, D Ward, A Plettenberg, et al.
HIV Medicine|October 6, 2020
Estimated glomerular filtration rate slopes on tenofovir alafenamideF Ibrahim, L Campbell, A C Bailey, et al.
Journal of Viral Hepatitis|April 17, 2018
Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infectionM Martinello, S Bhagani, E Gane, et al.
HIV Medicine|March 21, 2025
Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV-1 initiating first-line therapy: 5-year follow-up from two phase III studiesC Martorell, M Ramgopal, D Hagins, et al.
HIV Medicine|January 18, 2008
Patterns and predictors of the use of different antiretroviral drug regimens at treatment initiation in the UKP J Easterbrook, A N Phillips, T Hill, et al.
Journal of Viral Hepatitis|October 21, 2009
The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK - trends in HCV testing and the impact of HCV on HIV treatment outcomesJ Turner, L Bansi, R Gilson, et al.
HIV Medicine|November 9, 2010
Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late startersL Waters, M Fisher, J Anderson, et al.
Pageof 3